EDIT stock forecast
Our latest prediction for Editas Medicine Inc's stock price was made on the Jan. 12, 2021 when the stock price was at 75.00$.
In the short term (2weeks), EDIT's stock price should underperform the market by -2.20%. During that period the price should oscillate between -11.51% and +9.94%.
In the medium term (3months), EDIT's stock price should underperform the market by -6.86%. During that period the price should oscillate between -37.87% and +22.71%.
Get email alertsCreate a solid portfolio with EDIT
About Editas Medicine Inc
At the moment the company generates 92M USD in revenues.
On its last earning announcement, the company reported a loss of -1.66$ per share.
The book value per share is 4.84$
Three months stock forecastJan. 12, 2021
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92M | - | -108M | -118.30% | -91M | -1.66 | - | - | 56M | 4.84 | -99M | -7M | -106M |